Bartonellosis laboratory diagnosis, 5:33-39 Bartonella genus lineage and, 5:33, 34t future directions for translational research for, 5:38-39, 38t laboratory diagnostic tools for, 5:35-36 culture as, 5:35-36 next-generation sequencing methods as, 5:37-38 nucleic acid amplification as, 5:37 serology as, 5:36 overview of associated diseases and, 5:33-34 human as, 5:34 veterinary as, 5:33-34 pathogenesis and, 5:34-35 Candida infections epidemiology, See also Current epidemiology of Candida infections, 17:131-136 Cervical cancer screening updated guidelines, 13:95-101 adherence to guidelines and, 13:101 cytology (Papanicolaou smear) and, 13:95-97 atypical glandular cells and, 13:96 Bethesda classification system for, 13:96, 96t FDA-approved methods for, 13:95-96 future changes and, 13:102 high-risk HPV testing and, 13:97 FDA approval for, 13:97 molecular diagnostic tests available for, 13:97, 98-99t 